CORDANI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 93
EU - Europa 60
AS - Asia 13
Totale 166
Nazione #
US - Stati Uniti d'America 92
IT - Italia 24
CZ - Repubblica Ceca 15
CN - Cina 9
DE - Germania 8
RU - Federazione Russa 8
GB - Regno Unito 2
VN - Vietnam 2
BE - Belgio 1
HK - Hong Kong 1
IE - Irlanda 1
KR - Corea 1
MX - Messico 1
UA - Ucraina 1
Totale 166
Città #
Santa Cruz 16
Milan 15
Ashburn 8
Cedar Knolls 6
Frankfurt am Main 6
Wilmington 6
Fairfield 5
Ann Arbor 4
Beijing 4
Chicago 2
Dong Ket 2
Fleming Island 2
Las Vegas 2
Ningbo 2
Woodbridge 2
Wuhan 2
Andover 1
Atlanta 1
Auburn 1
Cambridge 1
Central 1
Chengdu 1
Council Bluffs 1
Cusano Milanino 1
Dublin 1
Gallarate 1
Henderson 1
Houston 1
Lake Forest 1
Lissone 1
Los Angeles 1
Monza 1
Mountain View 1
Phoenix 1
Provo 1
Rome 1
San Jose 1
Seattle 1
Seoul 1
University Park 1
Totale 108
Nome #
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes, file e39773b3-cf4a-35a3-e053-3a05fe0aac26 94
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes, file e39773b7-9e90-35a3-e053-3a05fe0aac26 46
Metronomic chemotherapy, file f2eee166-98f2-4bee-ab58-66160a56fee2 7
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study, file 2052bb4d-aec0-4ba6-a359-214e4ab70a8e 5
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows, file 82223b54-a726-4d6a-87f3-ddeb5a896f55 5
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story, file a5c9461e-6d4d-4552-b724-60fff3d9a1e2 4
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer, file e39773b8-4de8-35a3-e053-3a05fe0aac26 4
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC), file 26d56956-a0c2-4e1f-9bda-62d133e68537 3
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation, file a2ca98f3-5510-4515-95a6-2e98ce14af0c 2
Totale 170
Categoria #
all - tutte 437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20183 0000 00 00 0003
2018/201911 0010 20 00 2123
2019/20203 1000 00 00 0110
2020/202122 0231 12 12 3322
2021/202250 1054 22 35 12205
2022/202376 38166 22 112 115100
Totale 170